Prelude Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-251,341
| Closed | -$560K | – | 1694 |
|
|
2017
Q4 | $560K | Buy |
251,341
+111,637
| +80% | +$249K | 0.05% | 341 |
|
|
2017
Q3 | $405K | Sell |
139,704
-54,740
| -28% | -$159K | 0.04% | 386 |
|
|
2017
Q2 | $865K | Sell |
194,444
-305,854
| -61% | -$1.36M | 0.08% | 211 |
|
|
2017
Q1 | $2.33M | Buy |
500,298
+276,862
| +124% | +$1.29M | 0.22% | 98 |
|
|
2016
Q4 | $1.36M | Buy |
223,436
+85,566
| +62% | +$521K | 0.16% | 150 |
|
|
2016
Q3 | $760K | Buy |
+137,870
| New | +$760K | 0.08% | 221 |
|
|
2016
Q2 | – | Sell |
-10,000
| Closed | -$28K | – | 1771 |
|
|
2016
Q1 | $28K | Sell |
10,000
-18,900
| -65% | -$52.9K | ﹤0.01% | 994 |
|
|
2015
Q4 | $164K | Buy |
28,900
+18,500
| +178% | +$105K | 0.03% | 599 |
|
|
2015
Q3 | $55K | Sell |
10,400
-16,600
| -61% | -$87.8K | 0.01% | 960 |
|
|
2015
Q2 | $224K | Buy |
+27,000
| New | +$224K | 0.03% | 498 |
|
|
2014
Q4 | – | Sell |
-15,000
| Closed | -$42K | – | 2159 |
|
|
2014
Q3 | $42K | Hold |
15,000
| – | – | 0.01% | 1344 |
|
|
2014
Q2 | $61K | Sell |
15,000
-20,000
| -57% | -$81.3K | 0.01% | 1153 |
|
|
2014
Q1 | $186K | Buy |
35,000
+19,790
| +130% | +$105K | 0.02% | 665 |
|
|
2013
Q4 | $84K | Hold |
15,210
| – | – | 0.01% | 847 |
|
|
2013
Q3 | $69K | Hold |
15,210
| – | – | 0.01% | 781 |
|
|
2013
Q2 | $65K | Buy |
+15,210
| New | +$65K | 0.01% | 700 |
|